Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Acura Pharmaceuticals Net Income (Quarterly): -0.262M for Sept. 30, 2021
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.029M |
| September 30, 2021 | -0.262M |
| June 30, 2021 | -0.387M |
| March 31, 2021 | -0.259M |
| December 31, 2020 | -0.243M |
| September 30, 2020 | -0.678M |
| June 30, 2020 | 0.308M |
| March 31, 2020 | -0.595M |
| December 31, 2019 | 0.155M |
| September 30, 2019 | 0.20M |
| June 30, 2019 | -3.341M |
| March 31, 2019 | -0.788M |
| December 31, 2018 | 0.008M |
| September 30, 2018 | -1.095M |
| June 30, 2018 | -1.261M |
| March 31, 2018 | -1.494M |
| December 31, 2017 | -1.738M |
| September 30, 2017 | -2.20M |
| June 30, 2017 | -2.149M |
| March 31, 2017 | 0.405M |
| December 31, 2016 | 1.534M |
| September 30, 2016 | -2.25M |
| June 30, 2016 | -3.288M |
| March 31, 2016 | -3.384M |
| December 31, 2015 | -0.916M |
| Date | Value |
|---|---|
| September 30, 2015 | -2.649M |
| June 30, 2015 | -2.663M |
| March 31, 2015 | 1.239M |
| December 31, 2014 | -2.696M |
| September 30, 2014 | -2.904M |
| June 30, 2014 | -3.521M |
| March 31, 2014 | -4.088M |
| December 31, 2013 | -3.417M |
| September 30, 2013 | -3.19M |
| June 30, 2013 | -3.076M |
| March 31, 2013 | -4.218M |
| December 31, 2012 | -3.016M |
| September 30, 2012 | -2.14M |
| June 30, 2012 | -2.179M |
| March 31, 2012 | -2.333M |
| December 31, 2011 | -1.646M |
| September 30, 2011 | -2.141M |
| June 30, 2011 | 17.03M |
| March 31, 2011 | -2.857M |
| December 31, 2010 | -2.927M |
| September 30, 2010 | -2.553M |
| June 30, 2010 | -3.192M |
| March 31, 2010 | -4.035M |
| December 31, 2009 | -4.084M |
| September 30, 2009 | -3.954M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-3.341M
Minimum
Jun 2019
0.308M
Maximum
Jun 2020
-0.4612M
Average
-0.259M
Median
Mar 2021
Net Income (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.108M |
| Palatin Technologies Inc | -7.844M |
| iBio Inc | -8.211M |
| Theriva Biologics Inc | -5.485M |
| Oragenics Inc | -12.75M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.27M |
| Total Expenses (Quarterly) | 0.801M |
| EPS Diluted (Quarterly) | -0.0035 |